Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.
about
Is neurodegenerative disease a long-latency response to early-life genotoxin exposure?Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease.Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrowCerebral cortical Aβ42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE.Aberrant detergent-insoluble excitatory amino acid transporter 2 accumulates in Alzheimer disease.Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseasePallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus.Quantitative proteomics for identifying biomarkers for tuberculous meningitis.Detergent-insoluble EAAC1/EAAT3 aberrantly accumulates in hippocampal neurons of Alzheimer's disease patients.Quantitation and mapping of cerebral detergent-insoluble proteins in the elderly.Proteomics of human neurodegenerative diseasesDifferent patterns of cerebral injury in dementia with or without diabetes.Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.An iTRAQ-based proteomic analysis reveals dysregulation of neocortical synaptopodin in Lewy body dementiasAblation of the microglial protein DOCK2 reduces amyloid burden in a mouse model of Alzheimer's disease.Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.
P2860
Q26824755-B1E72013-12B5-4F18-80F3-CF6999E6C6CDQ33615147-45B01597-5469-458C-ABBC-CD38E2D544B1Q33947287-0EC4D5B2-BCEC-46B2-ABF1-47F5CA1CF8C2Q34963974-2D5459BB-323F-4D63-AAE4-C20FDBB11021Q34989710-B3FBC6C3-37A6-403C-B09D-939684A870F2Q35125001-77E3C1C0-C1C6-4902-AC82-8900D46EF58DQ36395775-1CC46E04-8026-4EAD-9A1B-A82FD3891D0DQ36609936-2115AE0F-FBB7-4C77-8AF0-5FD896AB4606Q37132181-C88CD2D9-73E1-4006-90B9-7B0EF016F85CQ37246539-CCF892C3-9964-402B-A733-86FFA8798A2FQ37260477-4D66899E-E538-4983-9479-B049373068A2Q37397970-11DDAA08-8E54-445F-96E3-B981A1EE7BFFQ37691267-AAE9CF54-A961-46FC-A202-D6FC31563594Q38628562-68C7C72F-D5D2-4B68-A708-4C3EE7591708Q43224814-4059D3AA-4598-4B8F-8F07-CE5A141C37BFQ47869899-6D371CFD-AE65-4D6A-8E51-1916F232231B
P2860
Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Quantitative proteomics identi ...... rogressive supranuclear palsy.
@ast
Quantitative proteomics identi ...... rogressive supranuclear palsy.
@en
type
label
Quantitative proteomics identi ...... rogressive supranuclear palsy.
@ast
Quantitative proteomics identi ...... rogressive supranuclear palsy.
@en
prefLabel
Quantitative proteomics identi ...... rogressive supranuclear palsy.
@ast
Quantitative proteomics identi ...... rogressive supranuclear palsy.
@en
P2093
P2860
P921
P1476
Quantitative proteomics identi ...... rogressive supranuclear palsy.
@en
P2093
Catherine Pan
Daniel P Perl
Douglas R Galasko
Elaine R Peskind
Izabela Sokal
James B Leverenz
Jing Zhang
Mary Brodey
Thomas J Montine
P2860
P304
P356
10.2353/AJPATH.2007.070015
P407
P577
2007-08-03T00:00:00Z